Pharmaceutical Preparations · DE · CIK 1770069
Develops circuit-specific treatments for central nervous system disorders by targeting neural circuits causally linked to disease
Comparable business profile · signals at a glance
In the 90 days to Feb 24, 2026: 2 insiders bought $694K · 1 sold $1.4M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 24, 2026 | Malenka Robert C.Director | Sell | 736 | $18.15 | $13K |
| Feb 23, 2026 | Malenka Robert C.Director | Sell | 10,788 | $18.39 | $198K |
| Feb 23, 2026 | Malenka Robert C.Director | Sell | 476 | $19.06 | $9K |
| Feb 20, 2026 | Pavlov GeorgeDirector | Buy | 9,920 | $17.86 | $177K |
| Feb 20, 2026 | Malenka Robert C.Director | Sell | 2,195 | $18.03 | $40K |
| Feb 19, 2026 | Pavlov GeorgeDirector | Buy | 4,422 | $17.57 | $78K |
| Feb 18, 2026 | Pavlov GeorgeDirector | Buy | 10,658 | $17.48 | $186K |
| Feb 13, 2026 | Malenka Robert C.Director | Sell | 12,116 | $18.21 | $221K |
| Feb 11, 2026 | Malenka Robert C.Director | Sell | 241 | $18.00 | $4K |
| Feb 10, 2026 | Garnett Timothy JohnDirector | Buy | 14,124 | $17.89 | $253K |
| Feb 10, 2026 | Malenka Robert C.Director | Sell | 6,622 | $18.12 | $120K |
| Feb 3, 2026 | Malenka Robert C.Director | Sell | 1 | $18.00 | $18 |
| Feb 2, 2026 | Malenka Robert C.Director | Sell | 7,039 | $18.02 | $127K |
| Jan 30, 2026 | Malenka Robert C.Director | Sell | 6,612 | $18.11 | $120K |
| Jan 29, 2026 | Malenka Robert C.Director | Sell | 21,262 | $18.55 | $394K |
| Jan 28, 2026 | Malenka Robert C.Director | Sell | 5,860 | $18.61 | $109K |
| Jan 28, 2026 | Malenka Robert C.Director | Sell | 664 | $19.05 | $13K |
| Oct 28, 2025 | Catalyst4, Inc.TenPercentOwner | Buy | 5,441,176 | $17.00 | $92.5M |
| Oct 28, 2025 | Novo Holdings A/STenPercentOwner | Buy | 952,941 | $17.00 | $16.2M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.